GALA RENEE D
President & CEO
GALA RENEE D has filed 9 SEC Form 4 filings (11 transaction rows) across 2 companies, including JAZZ, DXCM, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Oct 7, 2026.
On the most recent filing, GALA RENEE D is listed as President & CEO at Jazz Pharmaceuticals plc. Inside the rolling window, GALA RENEE D reported no open-market purchases and 2 open-market sales totaling $959K in JAZZ. The largest disclosed transaction in the window is a sale of 2,000 JAZZ shares on Sep 8, 2026, worth $486K.
Companies traded
Other insiders at JAZZ
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$959K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GALA RENEE D made?
GALA RENEE D has filed 9 SEC Form 4 filings (11 transaction rows) across 2 companies, including JAZZ, DXCM since 2025.
Which companies does GALA RENEE D trade?
GALA RENEE D has filed SEC Form 4 disclosures for 2 companies, including JAZZ, DXCM.
When was GALA RENEE D's most recent SEC Form 4 filing?
GALA RENEE D's most recent SEC Form 4 filing on Tracefour is dated Oct 7, 2026.
What is GALA RENEE D's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, GALA RENEE D is listed as President & CEO.
What is GALA RENEE D's total buy and sell value in the current window?
Inside the rolling retention window, GALA RENEE D bought $0 and sold $959K based on SEC Form 4 filings.
What was GALA RENEE D's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,000 JAZZ shares on 2026-09-08, worth $486K, per SEC Form 4 filings.